Perindopril + amlodipine + if necessary, hydrochlorothiazide + olmesartan/amlodipine + hydrochlorothiazide, if necessary.
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Hypertension
Conditions
Hypertension
Trial Timeline
Apr 1, 2010 → Dec 1, 2012
NCT ID
NCT01101009About Perindopril + amlodipine + if necessary, hydrochlorothiazide + olmesartan/amlodipine + hydrochlorothiazide, if necessary.
Perindopril + amlodipine + if necessary, hydrochlorothiazide + olmesartan/amlodipine + hydrochlorothiazide, if necessary. is a approved stage product being developed by Daiichi Sankyo for Hypertension. The current trial status is completed. This product is registered under clinical trial identifier NCT01101009. Target conditions include Hypertension.
What happened to similar drugs?
20 of 20 similar drugs in Hypertension were approved
Approved (20) Terminated (1) Active (0)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01101009 | Approved | Completed |
Competing Products
20 competing products in Hypertension